SEC Form 4 · accession 0001250853-19-000034
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hangjun Zhan
Officer — Chief Scientific Officer
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 8:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 22, 2019 | M | 6,250 | — | A | 39,397 | D | |
| Common StockF3 | Jan 22, 2019 | F | 2,305 | $10.12 | D | 37,092 | D | |
| Common StockF3 | Jan 23, 2019 | F | 2,132 | $9.945 | D | 34,960 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Jan 22, 2019 | M | 6,250 | D | — | — | Common Stock | 6,250 | 18,750 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2Includes 2,000 shares acquired under the Kindred Biosciences, Inc. 2014 Employee Stock Purchase Plan (the "ESPP") on May 31, 2018 and 2,000 shares acquired under the ESPP on November 30, 2018.
- F3These shares are being surrendered to satisfy a tax withholding obligation of the reporting person.
- F4On January 22, 2018, the reporting person was granted 25,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.